2021 American Transplant Congress
Donor Derived Cell-free DNA Kinetics Early After Kidney Transplant in Patients with Delayed Graft Function Who Received Kidneys from Donation After Cardiac Death Donors
Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD
*Purpose: Delayed graft function (DGF) may reduce long-term kidney allograft survival due to ischemia-reperfusion injury and rejection. Donor Derived Cell-Free DNA (dd-cfDNA) is proposed to…2021 American Transplant Congress
Cleveland Clinic Experience with Cadaveric Uterus Transplant
1Cleveland Clinic, Cleveland, OH, 2University Hospital, Cleveland, OH
*Purpose: Uterus transplantation (UTx) is the only treatment for women with uterine factor infertility (UFI). The majority of overall experience is from living donation. Little…2021 American Transplant Congress
Evaluation of Serum Klotho Levels at Early Kidney Post-Transplant
*Purpose: Klotho expression is lowered in patients with chronic kidney disease (CKD). After kidney transplant (KT), serum Klotho levels could be significantly increased compared to…2021 American Transplant Congress
The Clinical Significance of Preformed Anti-HLA-DQ Donor-specific Antibodies on Allograft Outcomes in Kidney Transplantation
*Purpose: De-novo anti-HLA-DQ donor-specific antibody (DSA) has been identified as a risk factor for late graft dysfunction and graft loss in kidney transplantation (KT). The…2021 American Transplant Congress
Predicted Heart Mass Difference as a Risk Factor for Severe Primary Graft Dysfunction in the Contemporary Era of Heart Transplantation: A Report from the International Consortium on Primary Graft Dysfunction
*Purpose: Primary Graft Dysfunction (PGD) increases early mortality after heart transplant (HT). Predicted heart mass (PHM) difference may be a risk factor for PGD. Lack…2021 American Transplant Congress
Medical Costs in the Year Following Kidney Transplantation: Relationships with Renal Function and Graft Failure
*Purpose: We describe relationships between total medical costs in the first year following kidney transplant with overall renal function as measured by: 1) estimated glomerular…2021 American Transplant Congress
De Novo Atypical Hemolytic Uremic Syndrome (aHUS) in Kidney Transplant Recipients from the Same Donor: Possible Role of Two Genetic Hits
*Purpose: Thrombotic microangiopathy (TMA) is an uncommon and potentially serious complication of kidney transplantation. Atypical hemolytic uremic syndrome (aHUS) is a type of TMA most…2021 American Transplant Congress
Allograft Function and Baseline Donor Derived Cell Free DNA in Kidney Transplant Recipients: One Size Doesn’t Fit All
Allegheny General Hospital, Allegheny Health Network, Pittsburgh, PA
*Purpose: Donor derived cell free DNA (dd-cfDNA) is increasingly used to predict acute rejection in kidney allografts . Cell free DNA fragments are constantly released…2021 American Transplant Congress
Combined Heart-liver Transplantation in Patients with Familial Amyloidosis – Analysis of Optn/Unos Database
Virginia Commonwealth University, Richmond, VA
*Purpose: We compared the outcomes after combined heart-liver transplant (CHLT) for patients with Familial Amyloidosis (FA) versus other indications (primary cardiac:congenital heart disease and idiopathic…2021 American Transplant Congress
Transplant Center Volume in High-risk Recipient Association with Graft and Patient Survival
Transplant, Washington University, Saint Louis, MO
*Purpose: Evaluation of high-risk recipients in transplant centers involves an intensive multidisciplinary medical evaluation and requires extensive coordination amongst various teams to follow-up on these…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 64
- Next Page »